drugset / Trial / NCT00736632
Vitamin D, Insulin Resistance, and Cardiovascular Disease
Completed
125 enrolled
Washington University School of Medicine
American Diabetes Association · collabNational Heart, Lung, and Blood Institute (NHLBI) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
In recent years, vitamin D has been shown not only to be important for bone and calcium metabolism but also for homeostasis of critical tissues involved in vascular disease in patients with diabetes. Epidemiological studies indicated the high prevalence of vitamin D deficiency among Type 2 DM patients and suggest an increased risk of cardiovascular disease and hypertension with low vitamin D levels. The objective of this proposal is to evaluate the effects of vitamin D replacement on blood pressure control and vascular disease in vitamin D deficient hypertensive patients with diabetes
Timeline
- Start
- 2006-05
- Primary completion
- 2019-01-13
- Completion
- 2019-01-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cholecalciferol | Other / unclassified | 4000 iu | Oral |
| Background | Calcium carbonate | Other / unclassified | 500 mg | Oral |